The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Ilov N.N.

Astrakhan State Medical University;
Federal Center for Cardiovascular Surgery

Surikova O.N.

Federal Center for Cardiovascular Surgery

Boytsov S.A.

Chazov National Medical Research Center for Cardiology

Palnikova O.V.

Astrakhan State Medical University;
Federal Center for Cardiovascular Surgery

Karimov I.R.

Astrakhan State Medical University

Nechepurenko A.A.

Federal Center for Cardiovascular Surgery

Indicators of structural and electrical atrial remodeling in predicting the risk of ventricular tachyarrhythmia in patients with chronic heart failure

Authors:

Ilov N.N., Surikova O.N., Boytsov S.A., Palnikova O.V., Karimov I.R., Nechepurenko A.A.

More about the authors

Journal: Russian Cardiology Bulletin. 2023;18(3): 60‑66

Read: 1347 times


To cite this article:

Ilov NN, Surikova ON, Boytsov SA, Palnikova OV, Karimov IR, Nechepurenko AA. Indicators of structural and electrical atrial remodeling in predicting the risk of ventricular tachyarrhythmia in patients with chronic heart failure. Russian Cardiology Bulletin. 2023;18(3):60‑66. (In Russ.)
https://doi.org/10.17116/Cardiobulletin20231803160

Recommended articles:
Clinical mani­festation of apical hype­rtrophic cardiomyopathy by syncope in the elde­rly. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):237-243
Intraoperative myocardial infa­rction or repe­rfusion syndrome? Features of ECG diagnostics. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(4):428-433

References:

  1. Tsang TS, Barnes ME, Gersh BJ, Takemoto Y, Rosales AG, Bailey KR, Seward JB. Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography. Journal of the American College of Cardiology. 2003;42:1199-1205. https://doi.org/10.1016/S0735-1097(03)00943-4
  2. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal. 2021;42:3599-3726. https://doi.org/10.1093/eurheartj/ehab368
  3. Ilov NN, Arnaudova KS, Nechepurenko AA, Yasenyavskaya AL, Bashkina OA, Samotrueva MA. Role of the cardiac extracellular matrix in the onset and progression of heart failure. Russian Journal of Cardiology. 2021;26: (2S):4363. (In Russ.) https://doi.org/10.15829/1560-4071-2021-4362
  4. Shen MJ, Arora R, Jalife J. Atrial Myopathy. JACC: Basic to Translational Science. 2019;4:640-654.  https://doi.org/10.1016/j.jacbts.2019.05.005
  5. Nagel C, Luongo G, Azzolin L, Schuler S, Dössel O, Loewe A. Non-Invasive and Quantitative Estimation of Left Atrial Fibrosis Based on P Waves of the 12-Lead ECG — A Large-Scale Computational Study Covering Anatomical Variability. Journal of Clinical Medicine. 2021;10:1797. https://doi.org/10.3390/jcm10081797
  6. Andlauer R, Seemann G, Baron L, Dössel O, Kohl P, Platonov P, Loewe A. Influence of left atrial size on P-wave morphology: differential effects of dilation and hypertrophy. Europace. 2018;20(suppl 3):36-44.  https://doi.org/10.1093/europace/euy231
  7. Ilov NN, Boytsov SA, Stompel DR, Palnikova OV, Nechepurenko AA. Echocardiographic Predictors of Ventricular Tachyarrhythmias in Patients With Cardioverter-Defibrillator Implanted for Primary Prevention of Sudden Cardiac Death. Results From a two-Year Prospective Follow-up Study. Kardiologiia. 2022;62:11-18. (In Russ.). https://doi.org/10.18087/cardio.2022.11.n2122
  8. Ilov NN, Stompel DR, Boytsov SA, Palnikova O V, Nechepurenko AA. Perspectives on the Use of Transthoracic Echocardiography Results for the Prediction of Ventricular Tachyarrhythmias in Patients with Non-ischemic Cardiomyopathy. Rational Pharmacotherapy in Cardiology. 2022;18:251-260. (In Russ.). https://doi.org/10.20996/1819-6446-2022-06-01
  9. Rattanawong P, Upala S, Riangwiwat T, Jaruvongvanich V, Sanguankeo A, Vutthikraivit W, Chung EH. Atrial fibrillation is associated with sudden cardiac death: a systematic review and meta-analysis. Journal of Interventional Cardiac Electrophysiology. 2018;51:91-104.  https://doi.org/10.1007/s10840-017-0308-9
  10. Triposkiadis F, Pieske B, Butler J, Parissis J, Giamouzis G, Skoularigis J, Brutsaert D, Boudoulas H. Global left atrial failure in heart failure. European Journal of Heart Failure. 2016;18:1307-1320. https://doi.org/10.1002/ejhf.645
  11. Osman J, Tan SC, Lee PY, Low TY, Jamal R. Sudden Cardiac Death (SCD) — risk stratification and prediction with molecular biomarkers. Journal of Biomedical Science. 2019;26:39.  https://doi.org/10.1186/s12929-019-0535-8
  12. Sroubek J, Matos J, Locke A, Kaplinskiy V, Levine YC, Shen C, et al. N-terminal pro — B-type natriuretic peptide is a specific predictor of appropriate device therapies in patients with primary prevention implantable cardioverter-defibrillators. Heart Rhythm. 2021;18:71-78.  https://doi.org/10.1016/j.hrthm.2020.08.014
  13. National guidelines for determining the risk and prevention of sudden cardiac death. Working Group on the preparation of the text of recommendations: Shlyakhto E.V., Arutyunov G.P., Belenko Yu.N., Boytsov S.A. Chairman of the Committee of Experts: Ardashev A.V. 2nd edition. M.: Publishing house «Medpraktika-M»; 2018;247. (In Russ.).
  14. Ilov NN, Surikova ON, Boytsov SA, Zorin DA, Nechepurenko AA. Possibilities for predicting ventricular tachyarrhythmias in patients with heart failure with reduced ejection fraction based on surface electrocardiography. First results from a single-center prospective study. Russian Journal of Cardiology. 2021;26:4661. (In Russ.). https://doi.org/10.15829/1560-4071-2021-4661
  15. Kamel H, Hunter M, Moon YP, Yaghi S, Cheung K, Di Tullio MR, Okin PM, Sacco RL, Soliman EZ, Elkind MSV. Electrocardiographic left atrial abnormality and risk of stroke: Northern Manhattan Study. Stroke. 2015;46:3208-3212. https://doi.org/10.1161/STROKEAHA.115.009989
  16. Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen SA, Chugh SS, Corradi D, D’Avila A, Dobrev D, Fenelon G, Gonzalez M, Hatem SN, Helm R, Hindricks G, Ho SY, Hoit B, Jalife J, Kim Y-H, Lip GYH, Ma C-S, Marcus GM, Murray K, Nogami A, Sanders P, Uribe W, Van Wagoner DR, Nattel S; Document Reviewers. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication. Heart Rhythm. 2017;14:3-40.  https://doi.org/10.1016/j.hrthm.2016.05.028
  17. van Wijngaarden AL, de Riva M, Hiemstra YL, van der Bijl P, Fortuni F, Bax JJ, Delgado V, Marsan NA. Parameters associated with ventricular arrhythmias in mitral valve prolapse with significant regurgitation. Heart. 2021;107:411-418.  https://dx.doi.org/10.1136/heartjnl-2020-317451
  18. Kim YG, Choi YY, Han KD, Min K, Choi HY, Shim J, Choi J-I, Kim Y-H. Atrial fibrillation is associated with increased risk of lethal ventricular arrhythmias. Scientific Reports. 2021;11:18111. https://doi.org/10.1038/s41598-021-97335-y
  19. Vazquez R, Bayes-Genis A, Cygankiewicz I, Pascual-Figal D, Grigorian-Shamagian L, Pavon R, Gonzalez-Juanatey JR, Cubero JM, Pastor L, Ordonez-Llanos J, Cinca J, de Luna AB; MUSIC Investigators. The MUSIC Risk score: a simple method for predicting mortality in ambulatory patients with chronic heart failure. European Heart Journal. 2009;30(9):1088-1096. https://doi.org/10.1093/eurheartj/ehp032
  20. Inciardi RM, Bonelli A, Biering‐Sorensen T, Cameli M, Pagnesi M, Lombardi CM,Solomon SD, Metra M. Left atrial disease and left atrial reverse remodelling across different stages of heart failure development and progression: a new target for prevention and treatment. European Journal of Heart Failure. 2022;24:959-975.  https://doi.org/10.1002/ejhf.2562
  21. Latif SR, Nguyen VQ, Peters DC, Soufer A, Henry ML, Grunseich K, Testani J, Hur DJ, Huber S, Mojibian H, Dicks D, Sinusas AJ, Meadows JL, Papoutsidakis N, Jacoby D, Baldassarre LA. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy. International Journal of Cardiovascular Imaging. 2019;35:1309-1318. https://doi.org/10.1007/s10554-019-01551-7

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.